Proto-oncogene tyrosine-protein kinase Src

Details

Name
Proto-oncogene tyrosine-protein kinase Src
Kind
protein
Organism
Humans
Protein
Name UniProt ID
Proto-oncogene tyrosine-protein kinase Src P12931 Details

Drug Relations

Drug Relations
DrugBank ID Name Drug group Pharmacological action? Actions Details
DB01254 Dasatinib approved, investigational yes multitarget Details
DB01893 N6-Benzyl Adenosine-5'-Diphosphate experimental unknown Details
DB01908 RU85493 experimental unknown Details
DB01962 Phosphonotyrosine experimental unknown Details
DB02175 Malonic acid experimental unknown Details
DB02336 RU83876 experimental unknown Details
DB02432 RU90395 experimental unknown Details
DB02908 RU78783 experimental unknown Details
DB03104 2-[4-[(Z)-2-Acetamido-3-oxo-3-[[(3S)-2-oxo-1-[(4-phenylphenyl)methyl]azepan-3-yl]amino]prop-1-enyl]-2-formylphenyl]acetic acid experimental unknown Details
DB03268 RU82197 experimental unknown Details
DB03298 Phenylphosphate experimental unknown Details
DB03591 RU82209 experimental unknown Details
DB03712 RU85053 experimental unknown Details
DB03902 Oxalic Acid experimental unknown Details
DB04272 Citric acid approved, nutraceutical, vet_approved unknown Details
DB04495 Paratoulene phosphate experimental unknown Details
DB01678 RU84687 experimental unknown Details
DB04739 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE experimental unknown Details
DB04751 Purvalanol A experimental unknown Details
DB05184 XL228 investigational unknown Details
DB06137 Tirbanibulin approved, investigational yes inhibitor Details
DB06882 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea experimental unknown Details
DB06883 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea experimental unknown Details
DB03114 PAS219 experimental unknown Details
DB01866 RU79256 experimental unknown Details
DB01947 RU78262 experimental unknown Details
DB03828 RU78299 experimental unknown Details
DB03306 RU78300 experimental unknown Details
DB02762 RU79072 experimental unknown Details
DB03525 RU79073 experimental unknown Details
DB04080 RU78191 experimental unknown Details
DB07335 3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL experimental unknown Details
DB07662 PD-168393 experimental unknown Details
DB03217 DPI59 experimental unknown Details
DB07966 [4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile experimental unknown Details
DB03628 ISO24 experimental unknown Details
DB08052 PP-121 experimental unknown Details
DB08053 1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine experimental unknown Details
DB08054 1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine experimental unknown Details
DB08192 2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE experimental unknown Details
DB03023 (1-Tert-Butyl-3) - 4-Chloro-Phenyl 1 h-pyrazolo [3,4 - d]Pyrimidin-4-Ylamine experimental unknown Details
DB03078 PASBN experimental unknown Details
DB08462 N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE experimental unknown Details
DB08564 (2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide experimental unknown Details
DB06616 Bosutinib approved unknown inhibitor Details
DB08901 Ponatinib approved, investigational unknown inhibitor Details
DB09079 Nintedanib approved unknown inhibitor Details
DB12010 Fostamatinib approved, investigational unknown inhibitor Details